retatrutide clinical trials efficacy New Phase 3 data just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats subscription The weirdest investment trend Flavor:Chocolate + Vanilla

retatrutide clinical trials efficacy New Phase 3 data just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats subscription The weirdest investment trend Flavor:Chocolate + Vanilla

The weirdest investment trend of 2026? Being “Skinny”🧍 While everyone's watching AI money move, GLP-1s are quietly rewriting entire industries… $50B market. Tripling by 2030 and it's just getting started 👀 #venturecapital #

Semaglutide is positioned as part of a broader metabolic support strategy overseen by licensed healthcare professionals rather than a standalone weight loss solution

subscription

Flavor:Chocolate + Vanilla

These medications produce substantial weight loss